“Viral inhibition assay: a CD8 T cell neutralization assay for use in clinical trials of HIV-1 vaccine candidates.”, J Infect Dis, vol. 201, no. 5, pp. 720-9, 2010.
, “Viral Inhibition Assay: A CD8 T Cell Neutralization Assay for Use in Clinical Trials of Human Immunodeficiency Virus-1 Vaccine Candidates”, J Infect Dis, vol. 201, pp. 720-729, 2010.
, “Viral kinetics in untreated versus treated acute HIV infection in prospective cohort studies in Thailand.”, J Int AIDS Soc, vol. 20, no. 1, p. 21652, 2017.
, “Visual acuity after cataract surgery in patients with age-related macular degeneration: age-related eye disease study 2 report number 5.”, Ophthalmology, vol. 121, no. 6, pp. 1229-36, 2014.
, “Visual Acuity After Cataract Surgery in Patients with Age-Related Macular Degeneration: Age-Related Eye Disease Study 2 Report Number 5”, Ophthalmology, vol. 121, pp. 1229-1236, 2014.
, “Visual Acuity as an Outcome Measure in Clinical Trials of Retinal Diseases”, Ophthalmology, vol. 114, pp. 1804-1809, 2007.
, “Visual acuity as an outcome measure in clinical trials of retinal diseases.”, Ophthalmology, vol. 114, no. 10, pp. 1804-9, 2007.
, “Visual Acuity Loss Associated With Advanced AMD Fundus Lesions and With the Simplified AREDS AMD Severity Scale”, in Annual Meeting, Association for Research in Vision and Ophthalmology (ARVO), Fort Lauderdale, FL, 2007.
, “Visual Acuity Outcomes after Anti-Vascular Endothelial Growth Factor Treatment for Neovascular Age-Related Macular Degeneration: Age-Related Eye Disease Study 2 Report Number 19.”, Ophthalmol Retina, vol. 4, no. 1, pp. 3-12, 2020.
, “Visual acuity outcomes after cataract surgery in patients with age-related macular degeneration: age-related eye disease study report no. 27.”, Ophthalmology, vol. 116, no. 11, pp. 2093-100, 2009.
, “Visual Acuity Outcomes after Cataract Surgery in Patients with Age-Related Macular Degeneration; AREDS Report No. 27”, Ophthalmology, vol. 116, pp. 2093-100, 2009.
, “Visualization of Dietary Patterns and Their Associations With Age-Related Macular Degeneration.”, Invest Ophthalmol Vis Sci, vol. 58, no. 3, pp. 1404-1410, 2017.
, “Vitamin D Status of HIV- positive Patients with End Stage Liver Disease Enrolled in the Solid Organ Transplantation in HIV Multi-site Study”, Liver Transpl, vol. 20, pp. 156-164, 2014.
, “Vitamin D status of human immunodeficiency virus-positive patients with advanced liver disease enrolled in the solid organ transplantation in HIV: multi-site study.”, Liver Transpl, vol. 20, no. 2, pp. 156-64, 2014.
, “Vitamin E in the treatment of uveitis-associated macular edema.”, Am J Ophthalmol, vol. 141, no. 1, pp. 193-4, 2006.
, “Voriconazole pharmacokinetics following HSCT: results from the BMT CTN 0101 trial.”, J Antimicrob Chemother, vol. 71, no. 8, pp. 2234-40, 2016.
, “VRC 702: A Multicenter Phase 1 Study of Seasonal Influenza DNA Vaccine Prime Followed by the Trivalent Inactivated Vaccine (TIV) Compared to TIV-TIV in Children and Adolescents Ages 6-17 Years”, in 2014 Annual Conference on Vaccine Research, Bethesda, MD, 2014.
, “Wait List Status of Pediatric Dialysis Patients in North America”, Pediatr Transplant, vol. 15, pp. 376-383, 2011.
, “Wait list status of pediatric dialysis patients in North America.”, Pediatr Transplant, vol. 15, no. 4, pp. 376-83, 2011.
, , “Web-Based, Psychosocial Treatment for Substance Use Disorders in Community Treatment Settings”, Psychol Serv, vol. 9, pp. 212-214, 2012.
, “Web-based, psychosocial treatment for substance use disorders in community treatment settings.”, Psychol Serv, vol. 9, no. 2, pp. 212-4, 2012.
, “A Web-Based Study Product Verification Utility for Blinded Treatment of Food Allergy Subjects”, in The Society for Clinical Trials 32nd Annual Meeting, Vancouver, BC, Canada, 2011.
, , “Web-based versus Paper Administration of Common Ophthalmic Questionnaires: Comparison of Subscale Scores”, Ophthalmology, vol. 120, pp. 2151-2159, 2013.
,